An Index for Characterization of Natural and Non-Natural Amino Acids for Peptidomimetics

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Liang, Guizhao ^a,b   Liu, Yonglan ^a   Shi, Bozhi ^a   Zhao, Jun ^b   Zheng, Jie ^b  

^a CHONGQING UNIVERSITY   (China)

^b University of Akron   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NATURAL AMINO ACID; NON NATURAL AMINO ACID; PEPTIDOMIMETIC AGENT; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ARTICLE; BIOLOGICAL ACTIVITY; COMPUTER MODEL; CONTROLLED STUDY; HYDROGEN BOND; MATHEMATICAL COMPUTING; MATHEMATICAL PARAMETERS; NATURAL AND NONNATURAL AMINO ACID INDEX; PHYSICAL CHEMISTRY; PROCESS DEVELOPMENT; PROTEIN DATABASE; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY;

ALUMINUM SILICATES; AMINO ACIDS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; LEAST-SQUARES ANALYSIS; PEPTIDOMIMETICS; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REPRODUCIBILITY OF RESULTS;

EID: 84880746761     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067844     Document Type: Article

References (69)

1. Fjell CD, Hiss JA, Hancock RE, Schneider G, (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11: 37-51.
2. Zelzer M, Ulijn RV, (2010) Next-generation peptide nanomaterials: molecular networks, interfaces and supramolecular functionality. Chem Soc Rev 39: 3351-3357.
3. Welch BD, VanDemark AP, Heroux A, Hill CP, Kay MS, (2007) Potent D-peptide inhibitors of HIV-1 entry. Proc Natl Acad Sci U S A 104: 16828-16833.
4. Palmblad M, Drijfhout JW, Deelder AM, (2010) High resolution mass spectrometry for rapid characterization of combinatorial peptide libraries. J Comb Chem 12: 65-68.
5. Wimley WC, (2010) Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chemical Biology 5: 905-917.
6. Hicks RP, Bhonsle JB, Venugopal D, Koser BW, Magill AJ, (2007) De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. J Med Chem 50: 3026-3036.
7. Sievers SA, Karanicolas J, Chang HW, Zhao A, Jiang L, et al. (2011) Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature 475: 96-100.
8. Apostolopoulos V, Matsoukas J, Plebanski M, Mavromoustakos T, (2002) Applications of peptide mimetics in cancer. Curr Med Chem 9: 411-420.
9. Ko E, Liu J, Perez LM, Lu G, Schaefer A, et al. (2011) Universal Peptidomimetics. J Am Chem Soc.
10. Sun H, Nikolovska-Coleska Z, Yang CY, Qian D, Lu J, et al. (2008) Design of small-molecule peptidic and nonpeptidic Smac mimetics. Acc Chem Res 41: 1264-1277.
11. Olson GL, Bolin DR, Bonner MP, Bos M, Cook CM, et al. (1993) Concepts and progress in the development of peptide mimetics. J Med Chem 36: 3039-3049.
12. Smith GP, Petrenko VA, (1997) Phage Display. Chem Rev 97: 391-410.
13. Hansch C, Maloney PP, Fujita T, Muir RM, (1962) Correlation of Biological Activity of Phenoxyacetic Acids with Hammett Substituent Constants and Partition Coefficients. Nature 194: 178-180.
14. Liang G, Yang L, Chen Z, Mei H, Shu M, et al. (2009) A set of new amino acid descriptors applied in prediction of MHC class I binding peptides. Eur J Med Chem 44: 1144-1154.
15. Puzyn T, Leszczynska D, Leszczynski J, (2009) Toward the development of "nano-QSARs": advances and challenges. Small 5: 2494-2509.
16. Puzyn T, Rasulev B, Gajewicz A, Hu X, Dasari TP, et al. (2011) Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat Nanotechnol 6: 175-178.
17. Ianni JC, Annamalai V, Phuan P-W, Panda M, Kozlowski MC, (2006) A Priori Theoretical Prediction of Selectivity in Asymmetric Catalysis: Design of Chiral Catalysts by Using Quantum Molecular Interaction Fields. Angewandte Chemie International Edition 45: 5502-5505.
18. Hellberg S, Eriksson L, Jonsson J, Lindgren F, Sjostrom M, et al. (1991) Minimum analogue peptide sets (MAPS) for quantitative structure-activity relationships. Int J Pept Protein Res 37: 414-424.
19. Cocchi M, Johansson E, (1993) Amino Acids Characterization by GRID and Multivariate Data Analysis. Quantitative Structure-Activity Relationships 12: 1-8.
20. Collantes ER, Dunn WJ 3rd, (1995) Amino acid side chain descriptors for quantitative structure-activity relationship studies of peptide analogues. J Med Chem 38: 2705-2713.
21. Zaliani A, Gancia E, (1999) MS-WHIM Scores for Amino Acids: A New 3D-Description for Peptide QSAR and QSPR Studies. Journal of Chemical Information and Computer Sciences 39: 525-533.
22. Mei H, Liao ZH, Zhou Y, Li SZ, (2005) A new set of amino acid descriptors and its application in peptide QSARs. Biopolymers 80: 775-786.
23. Ramos de Armas R, Gonzalez Diaz H, Molina R, Perez Gonzalez M, Uriarte E, (2004) Stochastic-based descriptors studying peptides biological properties: modeling the bitter tasting threshold of dipeptides. Bioorg Med Chem 12: 4815-4822.
24. Liang G, Yang L, Kang L, Mei H, Li Z, (2009) Using multidimensional patterns of amino acid attributes for QSAR analysis of peptides. Amino Acids 37: 583-591.
25. Liang GZ, Mei H, Zhou P, Zhou Y, Zl L, (2006) Study on quantitative structure-activity relationship by 3D holographic vector of atomic interaction field. Acta Physico-Chimica Sinica 22: 388-390.
26. Liang GZ, Zhou P, Zhou Y, Zhang QX, ZL L, (2006) New descriptors of aminoacids and their applications to peptide quantitative structure-activity relationship. Acta Chim Sin 64: 393-396.
27. Yang L, Shu M, Ma K, Mei H, Jiang Y, et al. (2010) ST-scale as a novel amino acid descriptor and its application in QSAM of peptides and analogues. Amino Acids 38: 805-816.
28. Tian F, Zhou P, Lv F, Song R, Li Z, (2007) Three-dimensional holograph vector of atomic interaction field (3D-HoVAIF): a novel rotation-translation invariant 3D structure descriptor and its applications to peptides. J Pept Sci 13: 549-566.
29. Tian F, Zhou P, Li Z, (2007) T-scale as a novel vector of topological descriptors for amino acids and its application in QSARs of peptides. Journal of Molecular Structure 830: 106-115.
30. Sneath PH, (1966) Relations between chemical structure and biological activity in peptides. J Theor Biol 12: 157-195.
31. Hellberg S, Sjostrom M, Skagerberg B, Wold S, (1987) Peptide quantitative structure-activity relationships, a multivariate approach. J Med Chem 30: 1126-1135.
32. Sandberg M, Eriksson L, Jonsson J, Sjostrom M, Wold S, (1998) New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. J Med Chem 41: 2481-2491.
33. Akamatsu M, (2002) Current State and Perspectives of 3D-QSAR. Current Topics in Medicinal Chemistry 2: 1381-1394.
34. Doytchinova IA, Flower DR, (2001) Toward the quantitative prediction of T-cell epitopes: coMFA and coMSIA studies of peptides with affinity for the class I MHC molecule HLA-A*0201. J Med Chem 44: 3572-3581.
35. Doytchinova IA, Flower DR, (2006) Modeling the peptide-T cell receptor interaction by the comparative molecular similarity indices analysis-soft independent modeling of class analogy technique. J Med Chem 49: 2193-2199.
36. Hou T, McLaughlin W, Lu B, Chen K, Wang W, (2006) Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis. J Proteome Res 5: 32-43.
37. Nettles JH, Jenkins JL, Bender A, Deng Z, Davies JW, et al. (2006) Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors. J Med Chem 49: 6802-6810.
38. Venkatraman V, Perez-Nueno VI, Mavridis L, Ritchie DW, (2010) Comprehensive comparison of ligand-based virtual screening tools against the DUD data set reveals limitations of current 3D methods. J Chem Inf Model 50: 2079-2093.
39. Zhou P, Tian FF, Wu YQ, Li ZL, Shang ZC, (2008) Quantitative Sequence-Activity Model (QSAM): Applying QSAR Strategy to Model and Predict Bioactivity and Function of Peptides, Proteins and Nucleic Acids. Current Computer-Aided Drug Design 4: 311-321.
40. Bak A, Polanski J, (2007) Modeling robust QSAR 3: SOM-4D-QSAR with iterative variable elimination IVE-PLS: Application to steroid, azo dye, and benzoic acid series. J Chem Inf Model 47: 1469-1480.
41. Vedani A, Dobler M, (2002) 5D-QSAR: the key for simulating induced fit? J Med Chem 45: 2139-2149.
42. Vedani A, Dobler M, Lill MA, (2005) Combining protein modeling and 6D-QSAR. simulating the binding of structurally diverse ligands to the estrogen receptor. J Med Chem 48: 3700-3703.
43. Neumann H, Wang K, Davis L, Garcia-Alai M, Chin JW, (2010) Encoding multiple unnatural amino acids via evolution of a quadruplet-decoding ribosome. Nature 464: 441-444.
44. Gfeller D, Michielin O, Zoete V, (2012) SwissSidechain: a molecular and structural database of non-natural sidechains. Nucleic Acids Res 41: D327-332.
45. Liang GZ, Li SZ, (2007) A new sequence representation as applied in better specificity elucidation for human immunodeficiency virus type 1 protease. Biopolymers 88: 401-412.
46. Liang G, Chen G, Niu W, Li Z, (2008) Factor analysis scales of generalized amino acid information as applied in predicting interactions between the human amphiphysin-1 SH3 domains and their peptide ligands. Chem Biol Drug Des 71: 345-351.
47. Tetko IV, Gasteiger J, Todeschini R, Mauri A, Livingstone D, et al. (2005) Virtual computational chemistry laboratory-design and description. J Comput Aided Mol Des 19: 453-463.
48. Cheng G, Li G, Xue H, Chen S, Bryers JD, et al. (2009) Zwitterionic carboxybetaine polymer surfaces and their resistance to long-term biofilm formation. Biomaterials 30: 5234-5240.
49. Hasegawa K, Miyashita Y, Funatsu K, (1997) GA strategy for variable selection in QSAR studies: GA-based PLS analysis of calcium channel antagonists. J Chem Inf Comput Sci 37: 306-310.
50. Gramatica P, Pilutti P, Papa E, (2004) Validated QSAR prediction of OH tropospheric degradation of VOCs: splitting into training-test sets and consensus modeling. J Chem Info Comp Sci 44: 1794-1802.
51. Wold S, Trygg J, Berglund A, Antti H, (2001) Some recent developments in PLS modeling. Chemometrics and Intelligent Laboratory Systems 58: 131-150.
52. Wold S, Sjöström M, Eriksson L, (2001) PLS-regression: a basic tool of chemometrics. Chemometrics and Intelligent Laboratory Systems 58: 109-130.
53. Helland IS, (2001) Some theoretical aspects of partial least squares regression. Chemometrics and Intelligent Laboratory Systems 58: 97-107.
54. Anfinsen CB, (1973) Principles that govern the folding of protein chains. Science 181: 223-230.
55. Asao M, Iwamura H, Akamatsu M, Fujita T, (1987) Quantitative structure-activity relationships of the bitter thresholds of amino acids, peptides, and their derivatives. J Med Chem 30: 1873-1879.
56. Molina E, Diaz HG, Gonzalez MP, Rodriguez E, Uriarte E, (2004) Designing antibacterial compounds through a topological substructural approach. J Chem Inf Comput Sci 44: 515-521.
57. Andersson PM, Sjöström M, Lundstedt T, (1998) Preprocessing peptide sequences for multivariate sequence-property analysis. Chemometrics and Intelligent Laboratory Systems 42: 41-50.
58. Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ, (1998) Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 339: 1285-1292.
59. Li Y-F, Zhu X-M, Liu F, Xiao C-S, Bian Y-F, et al. (2012) Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis. PLoS ONE 7: e37396.
60. Kuenzli A, Bucher HC, Anand I, Arutiunov G, Kum LC, et al. (2010) Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure. PLoS ONE 5: e9946.
61. Mao C, Solis DJ, Reiss BD, Kottmann ST, Sweeney RY, et al. (2004) Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires. Science 303: 213-217.
62. Vreuls C, Zocchi G, Genin A, Archambeau C, Martial J, et al. (2010) Inorganic-binding peptides as tools for surface quality control. J Inorg Biochem 104: 1013-1021.
63. Tamerler C, Duman M, Oren EE, Gungormus M, Xiong X, et al. (2006) Materials specificity and directed assembly of a gold-binding peptide. Small 2: 1372-1378.
64. Naik RR, Stringer SJ, Agarwal G, Jones SE, Stone MO, (2002) Biomimetic synthesis and patterning of silver nanoparticles. Nat Mater 1: 169-172.
65. Sarikaya M, Tamerler C, Jen AK, Schulten K, Baneyx F, (2003) Molecular biomimetics: nanotechnology through biology. Nat Mater 2: 577-585.
66. Donatan S, Yazici H, Bermek H, Sarikaya M, Tamerler C, et al. (2009) Physical elution in phage display selection of inorganic-binding peptides. Materials Science and Engineering: C 29: 14-19.
67. Kaur H, Raghava GP, (2004) A neural network method for prediction of beta-turn types in proteins using evolutionary information. Bioinformatics 20: 2751-2758.
68. Matthews BW, (1975) Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta 405: 442-451.
69. Kawashima S, Pokarowski P, Pokarowska M, Kolinski A, Katayama T, et al. (2008) AAindex: amino acid index database, progress report 2008. Nucleic Acids Res 36: D202-205.